Oncology News Central Peer-Spectives
Oncololgy News CentralPeer-Spectives is a podcast series that is moderated by Robert Figlin, MD, and features various oncology thought-leaders covering the latest clinical developments in a wide range of tumor types.
| Publishes | Twice weekly | Episodes | 140 | Founded | 5 years ago |
|---|---|---|---|---|---|
| Category | Science | ||||
Listen to this Podcast
Latest Episodes
Combination regimens improve survival in advanced EGFR-mutated NSCLC, but they also increase toxicity. Jorge Nieva, MD, shares how he talks with patients about potential adverse events. He
describes the options available for prophylaxis and how he t... more
Tackling central nervous system (CNS) disease in EGFR-mutated non-small cell lung cancer “is a huge problem, both from a quality-of-life perspective for patients and also from a longevity perspective,” explains Sid Devarakonda, MD, director of thorac... more
With multiple regimens available for advanced EGFRm NSCLC, selecting the best regimen for an individual patient is key. Jorge Nieva, MD, tells host Aakash Desai, MD, MPH, that the question
shouldn’t be about who needs more efficacy, but rather under... more
Progress in cancer care means that millions of patients are living longer lives, albeit without hope of a cure. What role can oncologists and other physicians play in helping to navigate these uncertain futures? “What is our obligation to them? How d... more
A recent study found a link between mRNA vaccination and improved cancer immunotherapy response. The preclinical data demonstrated impressive results, leading to big questions.
“We believe that [vaccination] actually does generate and even converts ... more
Survival data from the KEYNOTE-905 trial and insights into the use of circulating tumor DNA to guide treatment decisions from IMvigor011 made big waves in bladder cancer care at the European Society of Medical Oncology Annual Congress. “Overall, this... more
Options for the treatment of acute myeloid leukemia (AML) are rapidly expanding, says Amir Fathi, MD, associate professor of medicine at Harvard Medical School in Boston and program director of the Center for Leukemia at Massachusetts General Hospita... more
The artificial sweetener sucralose may impair the efficacy of cancer immunotherapy, according to a recent study published in Science. Although further research is needed before these findings can be translated into actionable information for patients... more
Key Facts
Similar Podcasts
People also subscribe to these shows.
Top Science Podcasts
Audience Metrics
Listeners, social reach, demographics and more for this podcast.
| Gender Skew | Location | Interests | |||
|---|---|---|---|---|---|
| Professions | Age Range | Household Income | |||
| Social Media Reach | |||||
Frequently Asked Questions About Oncology News Central Peer-Spectives
Where can I find podcast stats for Oncology News Central Peer-Spectives?
Rephonic provides a wide range of podcast stats for Oncology News Central Peer-Spectives. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Oncology News Central Peer-Spectives and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
How many listeners does Oncology News Central Peer-Spectives get?
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Oncology News Central Peer-Spectives, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
What are the audience demographics for Oncology News Central Peer-Spectives?
Rephonic provides comprehensive predictive audience data for Oncology News Central Peer-Spectives, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
How many subscribers and views does Oncology News Central Peer-Spectives have?
To see how many followers or subscribers Oncology News Central Peer-Spectives has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
Which podcasts are similar to Oncology News Central Peer-Spectives?
These podcasts share a similar audience with Oncology News Central Peer-Spectives:
How many episodes of Oncology News Central Peer-Spectives are there?
Oncology News Central Peer-Spectives launched 5 years ago and published 140 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
How do I contact Oncology News Central Peer-Spectives?
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Where can I see ratings and reviews for Oncology News Central Peer-Spectives?
Rephonic pulls ratings and reviews for Oncology News Central Peer-Spectives from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
How do I access podcast episode transcripts for Oncology News Central Peer-Spectives?
Rephonic provides full transcripts for episodes of Oncology News Central Peer-Spectives. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.